Lyopharm Limited in Kent, DA12 5BN

Description

Data updated on: 01-11-2023

Lyopharm Limited is officially located at Kent at 32 Windsor Road. Anyone can search for the company by its area code - DA12 5BN. This enterprise has been in the field on the English market for 22 years. This firm is registered under the number 04530378 and their current status is active. This company's SIC code is 74909 and their NACE code stands for Other professional, scientific and technical activities not elsewhere classified. Lyopharm Ltd reported its account information for the period that ended on 2022-09-30. The business latest confirmation statement was filed on 2023-09-10.

Mary W. is this firm's solitary director, that was selected to lead the company on 2002-09-10. To support the directors in their duties, the company has been utilizing the skills of Martin W. as a secretary for the last 22 years.

Financial data based on annual reports

Profit & Loss
Date of Accounts	2011-09-30	2012-09-30	2013-09-30	2014-09-30	2015-09-30	2016-09-30	2017-09-30	2018-09-30	2019-09-30	2020-09-30	2021-09-30	2022-09-30
Currency
Net Worth	657	-20	12 547	1 008	-115	-1 024	-1 073

Balance Sheet
Current Assets	39	69	16 800	2 131	1 008	101	64		142	191	126
Net Assets Liabilities							1 073	1 089	952	867	1 028	617
Cash Bank In Hand	39	69	16 800	2 131	1 008
Intangible Fixed Assets	1 410	705
Net Assets Liabilities Including Pension Asset Liability	657	-20	12 547	1 008	-115	-1 024	-1 073

Capital & Reserves
Called Up Share Capital	99	99	99	99	99
Profit Loss Account Reserve	558	-119	12 448	909	-214
Shareholder Funds	657	-20	12 547	1 008	-115	-1 024	-1 073

Other Financial Data
Called Up Share Capital Not Paid Not Expressed As Current Asset	99	99	99	99	99	99	99	99	99	99	99	99
Creditors							1 236	1 236	1 236	1 249	1 253	716
Fixed Assets	1 410	705					64	48	43	92
Net Current Assets Liabilities	-852	-824	12 448	2 131	1 008	101	64	1 236	1 094	1 058	1 127	716
Total Assets Less Current Liabilities	657	-20	12 547	2 230	1 107	200	163	1 089	952	382	225	617
Creditors Due After One Year				1 222	1 222	1 224	1 236
Creditors Due Within One Year	891	893	4 352	1 222
Intangible Fixed Assets Aggregate Amortisation Impairment		705	705
Intangible Fixed Assets Amortisation Charged In Period		705	705
Intangible Fixed Assets Cost Or Valuation	1 410	705	705
Number Shares Allotted		99	99		99
Par Value Share		1	1	1	1
Secured Debts			4 352	1 222	1 222
Share Capital Allotted Called Up Paid	99	99	99	99	99

Company staff

Martin W.

Role: Secretary

Appointed: 10 September 2002

Latest update: 3 April 2024

Mary W.

Role: Director

Appointed: 10 September 2002

Latest update: 3 April 2024

People with significant control

Executives with significant control over the firm are: Mary W. has substantial control or influence over the company owns 1/2 or less of company shares and has 1/2 or less of voting rights. Martin W. has substantial control or influence over the company owns 1/2 or less of company shares and has 1/2 or less of voting rights.

Mary W.

Notified on 6 April 2016

Nature of control:

1/2 or less of voting rights

substantial control or influence

right to manage directors

1/2 or less of shares

Martin W.

Notified on 6 April 2016

Nature of control:

1/2 or less of voting rights

right to manage directors

substantial control or influence

1/2 or less of shares

Accounts Documents

Account next due date	30 June 2024
Account last made up date	30 September 2022
Confirmation statement next due date	24 September 2024
Confirmation statement last made up date	10 September 2023

Annual Accounts 15 June 2013
Start Date For Period Covered By Report	2011-10-01
End Date For Period Covered By Report	2012-09-30
Date Approval Accounts	15 June 2013
Annual Accounts
Start Date For Period Covered By Report	2012-10-01
Annual Accounts 30 May 2015
Start Date For Period Covered By Report	2013-10-01
End Date For Period Covered By Report	2014-09-30
Date Approval Accounts	30 May 2015
Annual Accounts 19 June 2016
Start Date For Period Covered By Report	2014-10-01
End Date For Period Covered By Report	2015-09-30
Date Approval Accounts	19 June 2016
Annual Accounts 11 June 2017
Start Date For Period Covered By Report	2015-10-01
End Date For Period Covered By Report	2016-09-30
Date Approval Accounts	11 June 2017
Annual Accounts 3 June 2018
Start Date For Period Covered By Report	2016-10-01
End Date For Period Covered By Report	2017-09-30
Date Approval Accounts	3 June 2018
Annual Accounts
Start Date For Period Covered By Report	2017-10-01
End Date For Period Covered By Report	2018-09-30
Annual Accounts
Start Date For Period Covered By Report	2018-10-01
End Date For Period Covered By Report	2019-09-30
Annual Accounts
Start Date For Period Covered By Report	2019-10-01
End Date For Period Covered By Report	2020-09-30
Annual Accounts
Start Date For Period Covered By Report	2020-10-01
End Date For Period Covered By Report	2021-09-30
Annual Accounts
Start Date For Period Covered By Report	2021-10-01
End Date For Period Covered By Report	2022-09-30
Annual Accounts 18 June 2014
End Date For Period Covered By Report	2013-09-30
Date Approval Accounts	18 June 2014

Lyopharm Limited

General information

Name:

Office Address:

Description

Financial data based on annual reports

Company staff

Martin W.

Mary W.

Brighton Secretary Limited

Brighton Director Limited

People with significant control

Mary W.

Martin W.

Accounts Documents

Company filings

Filing category

Search other companies

Services (by SIC Code)

Company Age

Similar companies nearby

Closest companies